ArticleInternational journal of chronic obstructive pulmonary disease2026
Emphysema Phenotype and 1‑Year Readmission Risk After Acute Exacerbation of COPD: A Real-World Study Using Propensity Score-Based Methods.
Article in International journal of chronic obstructive pulmonary disease, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: The association between emphysema phenotype and readmission risk after acute exacerbation of chronic obstructive pulmonary disease (AECOPD) remains unclear. This real‑world study evaluated this association with rigorous confounding control. Methods: This retrospective cohort study included patients hospitalized for AECOPD (2023). Emphysema was diagnosed by chest CT. The outcome was 1‑year acute exacerbation‑related readmission. Propensity score matching (PSM), multiple-weighting methods, doubly robust analysis, Schoenfeld residuals test, Kaplan‑Meier curves, and subgroup analyses were used. Results: Among 875 patients, PSM yielded 171 matched pairs. Emphysema was associated with higher readmission risk in adjusted analysis (HR=1.64, 95% CI:1.17-2.32, p=0.005), and after PSM (HR=1.81, 95% CI:1.22-2.68, p=0.003). Results were consistent across all weighting methods. The Schoenfeld test satisfied the proportional hazards assumption. Kaplan‑Meier curves showed significantly lower readmission‑free survival in the emphysema group. Subgroup analyses revealed a stronger association in patients not using inhaled corticosteroids. Conclusion: Emphysema was associated with a higher risk of 1‑year readmission after AECOPD. The emphysema phenotype may aid risk stratification and guide individualized therapy, though these findings should be interpreted cautiously.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.